| Entry ID |
Original Release date |
Data summary |
Entry Title |
Citation Title |
Authors |
| 30610 |
2019-05-17 |
Chemical Shifts: 1 set
|
hMcl1 inhibitor complex |
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies.
|
A C Cheng, A Coxon, A Wei, A W Roberts, B Belmontes, B Lucas, C H Benes, D A Whittington, D C Huang, D Chui, D Moujalled, E Cajulis, G Moody, G Pomilio, J Canon, J D McClanaghan, J Gong, J Houze, J P Taygerly, J Sun, K S Keegan, L Damon, L Poppe, L Zhu, M Cardozo, M Vimolratana, M Zancanella, N A Paras, P Beltran, P E Hughes, P Greninger, R K Egan, S Caenepeel, S P Brown, T Osgood, X Huang, X Wang, Y Li |
| 27478 |
2018-09-20 |
Chemical Shifts: 1 set
|
Structural studies suggest aggregation as one of the modes of action for teixobactin |
Structural studies suggest aggregation as one of the modes of action for teixobactin.
|
Aaron J Peoples, Adrian J Lloyd, Amy L Spoering, Anita C Catherwood, Carl Oster, Christopher G Dowson, Dallas E Hughes, Grzegorz P Walkowiak, Jozef R Lewandowski, Julie A Tod, Kim Lewis, Torsten Herrmann |
| 27479 |
2018-09-20 |
Chemical Shifts: 1 set
|
Structural studies suggest aggregation as one of the modes of action for teixobactin |
Structural studies suggest aggregation as one of the modes of action for teixobactin.
|
Aaron J Peoples, Adrian J Lloyd, Amy L Spoering, Anita C Catherwood, Carl Oster, Christopher G Dowson, Dallas E Hughes, Grzegorz P Walkowiak, Jozef R Lewandowski, Julie A Tod, Kim Lewis, Torsten Herrmann |
| 27480 |
2018-09-20 |
Chemical Shifts: 1 set
|
Structural studies suggest aggregation as one of the modes of action for teixobactin |
Structural studies suggest aggregation as one of the modes of action for teixobactin.
|
Aaron J Peoples, Adrian J Lloyd, Amy L Spoering, Anita C Catherwood, Carl Oster, Christopher G Dowson, Dallas E Hughes, Grzegorz P Walkowiak, Jozef R Lewandowski, Julie A Tod, Kim Lewis, Torsten Herrmann |
